Gene · 10313
Papers1,763
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,763
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Optimization of Cd (II) removal from aqueous solution by natural hydroxyapatite/bentonite composite using response surface methodology. | Sci Rep | 2023 | 36991091 | PubTator, text mining | PubMed |
| [Hope when hopelessness beckons]. | Tidsskr Nor Laegeforen | 2023 | 36987904 | PubTator, text mining | PubMed |
| Medical-Grade Poly(Lactic Acid)/Hydroxyapatite Composite Films: Thermal and In Vitro Degradation Properties. | Polymers (Basel) | 2023 | 36987292 | PubTator, text mining | PubMed |
| Pickering Emulsions Based in Inorganic Solid Particles: From Product Development to Food Applications. | Molecules | 2023 | 36985475 | PubTator, text mining | PubMed |
| Glycosylation Analysis of Urinary Peptidome Highlights IGF2 Glycopeptides in Association with CKD. | Int J Mol Sci | 2023 | 36982475 | PubTator, text mining | PubMed |
| Preliminary Assessment of In Vivo Raman Spectroscopy Technique for Bone Quality Evaluation of Augmented Maxillary Sinus Floor. | Int J Environ Res Public Health | 2023 | 36981696 | PubTator, text mining | PubMed |
| Exploring the Formation Kinetics of Octacalcium Phosphate from Alpha-Tricalcium Phosphate: Synthesis Scale-Up, Determination of Transient Phases, Their Morphology and Biocompatibility. | Biomolecules | 2023 | 36979398 | PubTator, text mining | PubMed |
| From Balloon to Crystalline Structure in the Calcium Phosphate Flow-Driven Chemical Garden. | Langmuir | 2023 | 36972336 | PubTator, text mining | PubMed |
| Development of three-layer collagen scaffolds to spatially direct tissue-specific cell differentiation for enthesis repair. | Mater Today Bio | 2023 | 36969698 | PubTator, text mining | PubMed |
| Adjuvant transarterial chemoembolization timing after radical resection is an independent prognostic factor for patients with hepatocellular carcinoma. | Front Oncol | 2023 | 36969018 | PubTator, text mining | PubMed |
The role of three-dimensional scaffolds based on polyglycerol sebacate/ polycaprolactone/ gelatin in the presence of Nanohydroxyapatite in promoting chondrogenic differentiation of human adipose-derived mesenchymal stem cells. | Biol Proced Online | 2023 | 36964481 | PubTator, text mining | PubMed |
| Thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): Real world data of a Greek nationwide multicenter retrospective study. | Front Oncol | 2023 | 36959785 | PubTator, text mining | PubMed |
| Coronavirus subverts ER-phagy by hijacking FAM134B and ATL3 into p62 condensates to facilitate viral replication. | Cell Rep | 2023 | 36952345 | PubTator, text mining | PubMed |
| Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics. | J Nanobiotechnology | 2023 | 36944946 | PubTator, text mining | PubMed |
| Hospitals' Adoption of Mobile-Based Personal Health Record Systems and Patients' Characteristics: A Cross-Sectional Study Analyzing National Healthcare Big Data. | Inquiry | 2023 | 36927267 | PubTator, text mining | PubMed |
| Increased RTN3 phenocopies nonalcoholic fatty liver disease by inhibiting the AMPK-IDH2 pathway. | MedComm (2020) | 2023 | 36925557 | PubTator, text mining | PubMed |
| Vessels That Encapsulate Tumor Clusters (VETC) Predict cTACE Response in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 36915392 | PubTator, text mining | PubMed |
| The abdominal aortic aneurysm-related disease model based on machine learning predicts immunity and m1A/m5C/m6A/m7G epigenetic regulation. | Front Genet | 2023 | 36911406 | PubTator, text mining | PubMed |
| Towards Controlling the Local Bone Tissue Remodeling-Multifunctional Injectable Composites for Osteoporosis Treatment. | Int J Mol Sci | 2023 | 36902390 | PubTator, text mining | PubMed |
| POSS and SSQ Materials in Dental Applications: Recent Advances and Future Outlooks. | Int J Mol Sci | 2023 | 36901923 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10313/papers?page=13